|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Use of androgen deprivation therapy in prostate cancer: indications and prevalence显示文摘雄激素在前列腺癌症的发展,维护和前进起一个突出的作用。进为前列腺癌症病人的治疗范例的雄激素剥夺治疗的介绍导致了与临床上局部性或局部地先进的疾病为那些从一个幸存优点的许多好处,到在为有先进疾病的病人的症状控制的改进。然而,争吵留下包围这些神经质的途径的最佳的预定,持续时间和时间表。象 abiraterone 醋酸盐那样的更新的神经质的操作也与前列腺癌症为人被调查了并且将拓宽治疗选择。这评论与支持神经质的治疗的使用的每条途径,以及模式的前列腺癌症,他们的特定的指示和证据加亮对人可得到的各种各样的指导雄激素的治疗选择。 | Roisin M Connolly Michael A Carducci Emmanuel S Antonarakis | 2012 | Asian Journal of Andrology2012，14，2： | 8 |
| 2 | Role of rumination in the relationship between metacognition and shyness显示文摘AIM To explore the association between metacognitive beliefs, rumination and shyness in a non-clinical sample of adults. METHODS One hundred and three healthy subjects from the general population were enrolled in the study. Shyness was evaluated using the Revised Cheek and Buss Shyness Scale, rumination was assessed using the Ruminative Response Scale, metacognition was evaluated using the MetaCognitions Questionnaire 30, and anxiety levels were measured using the State Trait Anxiety Inventory form Y. Correlation analyses, mediation models and 95% bias-corrected and accelerated(BCaCI) bootstrapped analyses were performed. Mediation analyses were adjusted for sex and anxiety. RESULTS Shyness, rumination and metacognition were significantly correlated(P < 0.05). The relationship between metacognition and shyness was fully mediated by rumination(Indirect effect: 0.20; 95% BCaCI: 0.08-0.33).CONCLUSION These findings suggest an association between metacognition and shyness. Rumination mediated the relationship between metacognition and shyness, suggesting that rumination could be a cognitive strategy for shy people. Future research should explore the relationship between these constructs in more depth. | Sara Palmieri Giovanni Mansueto Simona Scaini Francesca Fiore Sandra Sassaroli Giovanni M Ruggiero Rosita Borlimi Bernardo J Carducci | 2018 | World Journal of Psychiatry2018，8，4： | 2 |
| 3 | Temsirolimus,Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma 显示文摘 | Hudes G Carducci M Tomczak P | 2007 | N Engl J Med2007，356，22： | 1 |
| 4 | Temsi- rolimus, interferon alfa, or both for advanced renal-cell carcinoma显示文摘 | HUDES G CARDUCCI M TOMCZAK P | 2007 | N Engl J Med2007，356，22： | 1 |
| 5 | Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group显示文摘 | Bubley GJ Carducci M Dahut W | 1999 | J Clin Oncol1999，17，： | 1 |
| 6 | Correlated increases of tumour necrosis factor-alpha,interleukin6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationship with disease severity 显示文摘 | Bonifati C carducci M Cordiali-Fei P | 1994 | Clin Exp Dermatol1994，19，5： | 1 |
| 7 | Denosumab ver- sus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a ran- domised, double-blind study显示文摘 | Fizazi K Carducci M Smith M | 2011 | Lancet2011，377，9768： | 1 |
| 8 | Guanidinoaeetate and creatine plus ereatinine assessment in physiologic fluid:an effec- tive diagnostic tool for the biochemical diagaosis of arginino: glycine amidinotransferase and guanidinoaeetate methyhransferase deficien- cies显示文摘 | CARDUCCI C BIRARELLI M LEUZZI V | 2002 | Clin them2002，48，10： | 1 |
| 9 | Dcnosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study显示文摘 | Fizazi K Carducci M Smith M | 2011 | Lancet2011，377，9768： | 1 |
| 10 | Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma 显示文摘 | Hudes G Carducci M Tomczak P | 2007 | NEnglJMed2007，356，22： | 1 |
| 11 | Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma显示文摘 | HUDES G CARDUCCI M TOMCZAK P | 2007 | N Engl J Med2007，356，22： | 1 |
| 12 | Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase Ⅱ , placebo-controlled trial 显示文摘 | CARDUCCI M A PADLEY R J BREUL J | 2003 | J Clin Oncol2003，21，4： | 1 |
| 13 | Temsirolimus,interferon alfa,or both for advanced renal-cell carcinoma显示文摘 | Hudes G Carducci M Tomczak P | | 0，，22： | 1 |
| 14 | Temsirolimus, interferon alfa,or both for advanced renal-cell carcinoma 显示文摘 | HADES G CARDUCCI M TOMCAT K P | 2007 | New Engl J Med2007，356，22： | 1 |
| 15 | The translationally controlled tumor protein is a novel calcium binding protein of the human placenta and regulates calcium handling in trophoblast cells显示文摘 | Arcuri F Papa S Meini A Carducci A Romagnoli R Bianchi L Riparbelli M G Sanchez J C Palmi M Tosi P Cintorino M | 2005 | Biol Reprod2005，73，4： | 1 |
| 16 | Denosumab versuszoledronic acid for treatment of bone metastases in men withcastration-resistant prostate cancer: a randomised, double-blind study 显示文摘 | Fizazi K Carducci M Smith M | 2011 | Lancet2011，377，9768： | 1 |
| 17 | Temsirolimus,interfer-on alfa,or both for advanced renal-cell carcinoma 显示文摘 | Hudes G Carducci M Tomczak P | 2007 | N Engl JMed2007，356，22： | 1 |
| 18 | Serum TNF-a levers correlate with disease severity and reduced by effective therapy in plaque-type psoriasis 显示文摘 | Mussi A Bonifati C Carducci M | 1997 | J Biol Regul Homeost Agents1997，11，3： | 1 |
| 19 | Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity 显示文摘 | Bonifati C Mussi A Carducci M | 1998 | Acta Derm Venereol1998，78，： | 1 |
| 20 | Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group 显示文摘 | Carducci M Dahut W | 1999 | J Clin Oncol1999，17，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员